Does Rallies show Form 4 insider transactions for NKTX?

Yes. Rallies tracks NKTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is NKTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NKTX. It does not provide personalized investment advice.

NKTX (Nkarta, Inc. Common Stock) Stock Analysis - Insider Trades

Nkarta, Inc. Common Stock (NKTX) is a publicly traded Healthcare sector company. As of May 21, 2026, NKTX trades at $2.80 with a market cap of $191.74M and a P/E ratio of -1.97. NKTX moved +4.10% today. Year to date, NKTX is +47.37%; over the trailing twelve months it is +55.56%. Its 52-week range spans $1.31 to $4.76. Analyst consensus is strong buy with an average price target of $12.50. Rallies surfaces NKTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading NKTX stock inside the company?

Recent NKTX insider activity includes HASTINGS PAUL J sold 26.05K, Mahmood Nadir sold 5.65K, HASTINGS PAUL J sold 1.79K, Shook David sold 8.64K, and Levin Alyssa sold 5.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

NKTX Key Metrics

Key financial metrics for NKTX
Metric	Value
Price	$2.80
Market Cap	$191.74M
P/E Ratio	-1.97
EPS	$-1.41
Dividend Yield	0.00%
52-Week High	$4.76
52-Week Low	$1.31
Volume	0
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-104.08M
Gross Margin	0.00%

Recent NKTX Insider Trades

HASTINGS PAUL J sold 26.05K (~$53.92K) on Jan 15, 2026.
Mahmood Nadir sold 5.65K (~$11.69K) on Jan 15, 2026.
HASTINGS PAUL J sold 1.79K (~$3.20K) on Jun 18, 2025.
Shook David sold 8.64K (~$19.00K) on Jan 15, 2025.
Levin Alyssa sold 5.84K (~$12.84K) on Jan 15, 2025.

Latest NKTX News

Nkarta Extends Cash Runway to 2029 with $266.7M, Expands Outpatient Dosing — May 12, 2026
Nkarta Advances NKX019 to 12 Billion-Cell Cycle, Secures $295M Runway — Mar 25, 2026

NKTX Analyst Consensus

5 analysts cover NKTX: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $12.50.

Common questions about NKTX

Who is trading NKTX stock inside the company?: Recent NKTX insider activity includes HASTINGS PAUL J sold 26.05K, Mahmood Nadir sold 5.65K, HASTINGS PAUL J sold 1.79K, Shook David sold 8.64K, and Levin Alyssa sold 5.84K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for NKTX?: Yes. Rallies tracks NKTX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is NKTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NKTX. It does not provide personalized investment advice.